AI Cancer Vaccine Startup Gamgee Raises $4M Led by Founders Fund
新智元 · wechat · 2026-08-23
After using AI (ChatGPT and AlphaFold) to design a personalized mRNA cancer vaccine that shrank his dog Rosie's tumor by 75%, developer Paul Conyngham founded Gamgee to industrialize the process, despite Rosie's passing due to production delays.
Business Progress:
- Funding: Raised $4M seed round led by Founders Fund with participation from YC.
- Model: Building a SaaS platform to reduce vaccine design time to 48 hours, targeting a $2,000 end-to-end cost.
- Vision: Addressing the needs of 6 million dogs with cancer in the US first, leveraging a data flywheel to improve models, with plans to expand to human "N-of-1" personalized medicine.
More from Venture
- Anthropic IPO at $2T would be 4x all SF IPOs combined — ethanniser · 2026-08-23
- Dropped Cross-Promos and Ads, Went All-In on SEO — Subscribers Now Grow on Autopilot — ayushtweetshere · 2026-08-23
- Higgsfield raises $400M at $5.4B valuation, ARR hits $700M building the agent layer atop video models — 创业邦 · 2026-08-23
- Skip the agency: use local AI agents to broker high-ticket deals for 20-30% cuts — aryanXmahajan · 2026-08-23
- VC Rushes to Specialized Vertical Models as Data Becomes the New Frontier — joecole · 2026-08-23
- Unitree IPO背后的天使投资人：140倍回报与对具身智能的押注 — 量子位 · 2026-08-23